Imagion Biosystems receives $300K order for supply of nanoparticles

Matthew Wygant Investor Updates, News

Imagion Biosystems Limited announced the NewPhase Ltd., an Israeli biotechnology company developing cancer treatments, has placed an order totaling approximately $300k for the supply of Imagion’s proprietary nanoparticles for 2020 to be used in the NewPhase product.

Read the announcement.